Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease

Journal of Clinical Laboratory Analysis
E S UmezawaA M Stolf

Abstract

This report describes differences in humoral immune response of acute and chronic phases of human Chagas disease. The reactivities of IgG, IgM, and IgA anti-Trypanosoma cruzi antibodies in serum samples from both groups of patients were compared by enzyme-linked immunosorbent assay (ELISA) employing either one of four antigenic fractions: mouse laminin (LAM), which reacts through Gal alpha 1-3Gal epitopes expressed on trypomastigote surface: whole intact trypomastigotes (TCT); trypomastigotes excreted/secreted antigens (TESA); and epimastigote alkaline extract (EAE). The selection of T. cruzi antigen preparations was based on their relative content of surface and internal antigens found in trypomastigote forms. The proportion of IgG reactive to carbohydrate epitopes was assessed through the decay of IgG reactivity from acute and chronic sera after m-periodate oxidation of solid-phase bound antigens. Trypomastigote and TESA antigens recognized by IgG from acute and chronic sera were also compared by immunoblotting. ELISA and immunoblotting data showed that: (1) the proportion of IgG directed to trypomastigote surface antigens was higher in acute than in chronic sera, whereas the opposite was found for internal antigens, (2) acut...Continue Reading

References

Jan 1, 1992·Memórias do Instituto Oswaldo Cruz·Z MedeirosM L Pires
Sep 1, 1991·Revista Do Instituto De Medicina Tropical De São Paulo·M A Shikanai-YasudaE R Arruda Júnior
Jan 1, 1991·Experimental Parasitology·M F GonçalvesW Colli
Jan 1, 1991·Infection·J E Fowler
May 15, 1989·Molecular and Biochemical Parasitology·J L AffranchinoA C Frasch
Apr 8, 1985·Journal of Immunological Methods·M P WoodwardR A Bloodgood
Jul 1, 1986·Molecular and Biochemical Parasitology·R Rangel-AldaoS Negri
Jan 1, 1988·Transactions of the Royal Society of Tropical Medicine and Hygiene·R GazzinelliZ Brener
Jan 1, 1980·Advances in Parasitology·Z Brener
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·B WåhlinP Perlmann
Nov 1, 1980·The Journal of protozoology·F G AraujoJ S Remington
Jul 1, 1993·Clinical and Experimental Immunology·M R GrauertM Hontebeyrie-Joskowciz
Mar 1, 1994·Revista Do Instituto De Medicina Tropical De São Paulo·A M LissaldoA M Stolf

❮ Previous
Next ❯

Citations

Jan 13, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maria Aparecida Shikanai-Yasuda, Noemia Barbosa Carvalho
Aug 31, 2001·Clinical and Diagnostic Laboratory Immunology·M NakazawaY M Gomes
Feb 4, 2006·Journal of Clinical Microbiology·Mariolga BerrizbeitiaBrian J Ward
Nov 13, 2012·PLoS Neglected Tropical Diseases·Anna M AfonsoRick L Tarleton
May 18, 2006·Emerging Infectious Diseases·Jose G Estrada-FrancoNisha Garg
Sep 16, 2003·Memórias do Instituto Oswaldo Cruz·Francisca Sosa-JuradoVictor M Monteón
Mar 16, 2005·Revista Da Sociedade Brasileira De Medicina Tropical·Adriano Gomes SilvaSilvio Favoreto Junior
Jun 10, 2000·Memórias do Instituto Oswaldo Cruz·E S Umezawa, J F Silveira
Dec 24, 2005·Expert Review of Vaccines·Nisha Garg, Vandanajay Bhatia
Jun 12, 1999·Thyroid : Official Journal of the American Thyroid Association·M KnobelG Medeiros-Neto
Jan 4, 2001·Clinical and Diagnostic Laboratory Immunology·F D CordeiroA J Romanha
Mar 13, 1998·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·L F UmekitaI Mota
Jul 26, 2018·Biomedicines·Leandra B JonesQiana L Matthews
Jul 18, 2019·Frontiers in Public Health·Kárita Cláudia Freitas LidaniThaisa Lucas Sandri
Sep 25, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·E ZúñigaA Gruppi
Dec 17, 1997·Journal of Clinical Microbiology·V M MonteónP A Lopez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.